Isobavachalcone From Cullen corylifolium Presents Significant Antibacterial Activity Against Clostridium difficile Through Disruption of the Cell Membrane

Background: Clostridium difficile infection (CDI) has been widely reported in human and animals around the world over the past few decades. The high relapse rate and increasing drug resistance of CDI make the discovery of new agents against C. difficile fairly urgent. This study aims to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xi-Wang, Yang, Ya-Jun, Qin, Zhe, Li, Shi-Hong, Bai, Li-Xia, Ge, Wen-Bo, Li, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356235/
https://www.ncbi.nlm.nih.gov/pubmed/35942219
http://dx.doi.org/10.3389/fphar.2022.914188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356235/
https://www.ncbi.nlm.nih.gov/pubmed/35942219
http://dx.doi.org/10.3389/fphar.2022.914188

Ejemplares similares